Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 640

1.

Lenvatinib as an Initial Treatment in Patients with Intermediate-Stage Hepatocellular Carcinoma Beyond Up-To-Seven Criteria and Child-Pugh A Liver Function: A Proof-Of-Concept Study.

Kudo M, Ueshima K, Chan S, Minami T, Chishina H, Aoki T, Takita M, Hagiwara S, Minami Y, Ida H, Takenaka M, Sakurai T, Watanabe T, Morita M, Ogawa C, Wada Y, Ikeda M, Ishii H, Izumi N, Nishida N.

Cancers (Basel). 2019 Jul 31;11(8). pii: E1084. doi: 10.3390/cancers11081084.

2.

The three criteria for radiological response on survival in patients with hepatocellular carcinoma treated with lenvatinib.

Kaneko S, Tsuchiya K, Kurosaki M, Kirino S, Inada K, Yamashita K, Osawa L, Hayakawa Y, Sekiguchi S, Watakabe K, Okada M, Wan W, Shimizu T, Higuchi M, Takaura K, Maeyashiki C, Tamaki N, Yasui Y, Takeguchi T, Takeguchi Y, Nakanishi H, Itakura J, Takahashi Y, Himeno Y, Izumi N.

Hepatol Res. 2019 Jul 26. doi: 10.1111/hepr.13416. [Epub ahead of print]

PMID:
31349377
3.

Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2017 (4th JSH-HCC Guidelines) a 2019 update.

Kokudo N, Takemura N, Hasegawa K, Takayama T, Kubo S, Shimada M, Nagano H, Hatano E, Izumi N, Kaneko S, Kudo M, Iijima H, Genda T, Tateishi R, Torimura T, Igaki H, Kobayashi S, Sakurai H, Murakami T, Watadani T, Matsuyama Y.

Hepatol Res. 2019 Jul 23. doi: 10.1111/hepr.13411. [Epub ahead of print]

PMID:
31336394
4.

Large-scale viral genome analysis identifies novel clinical associations between hepatitis B virus and chronically infected patients.

Podlaha O, Gane E, Brunetto M, Fung S, Chuang WL, Pan CQ, Jiang Z, Liu Y, Bhardwaj N, Mukherjee P, Flaherty J, Gaggar A, Subramanian M, Izumi N, Shalimar, Lim YS, Marcellin P, Buti M, Chan HLY, Agarwal K.

Sci Rep. 2019 Jul 19;9(1):10529. doi: 10.1038/s41598-019-46609-7.

5.

Wisteria floribunda agglutinin-positive mac-2 binding protein as an age-independent fibrosis marker in nonalcoholic fatty liver disease.

Tamaki N, Higuchi M, Kurosaki M, Kirino S, Osawa L, Watakabe K, Wang W, Okada M, Shimizu T, Takaura K, Takada H, Kaneko S, Yasui Y, Tsuchiya K, Nakanishi H, Itakura J, Takahashi Y, Enomoto N, Izumi N.

Sci Rep. 2019 Jul 12;9(1):10109. doi: 10.1038/s41598-019-46172-1.

6.

Efficacy and safety of glecaprevir/pibrentasvir as retreatment therapy for patients with genotype 2 chronic hepatitis C who failed prior sofosbuvir plus ribavirin regimen.

Kusakabe A, Kurosaki M, Itakura J, Joko K, Akahane T, Tsuji K, Kobashi H, Sohda T, Kimura H, Narita R, Furuta K, Izumi N.

Hepatol Res. 2019 Jun 17. doi: 10.1111/hepr.13387. [Epub ahead of print]

PMID:
31209976
7.

Impact of Perioperative Chemotherapy on Prognosis of Patients with Esophageal Carcinoma Undergoing Pulmonary Metastasectomy.

Komatsu H, Izumi N, Tsukioka T, Inoue H, Miyamoto H, Nishiyama N.

Ann Thorac Cardiovasc Surg. 2019 Jun 12. doi: 10.5761/atcs.oa.19-00075. [Epub ahead of print]

8.

Real-world efficacy of elbasvir and grazoprevir for hepatitis C virus (genotype 1): A nationwide, multicenter study by the Japanese Red Cross Hospital Liver Study Group.

Mashiba T, Joko K, Kurosaki M, Ochi H, Hasebe C, Akahane T, Sohda T, Tsuji K, Mitsuda A, Kimura H, Narita R, Ogawa C, Furuta K, Shigeno M, Okushin H, Ito H, Kusakabe A, Satou T, Kawanami C, Nakata R, Kobashi H, Tamada T, Ide Y, Yagisawa H, Morita A, Matsushita T, Okada K, Izumi N.

Hepatol Res. 2019 May 11. doi: 10.1111/hepr.13362. [Epub ahead of print]

PMID:
31077527
9.

Subgroup analysis of efficacy and safety of orantinib in combination with TACE in Japanese HCC patients in a randomized phase III trial (ORIENTAL).

Hidaka H, Izumi N, Aramaki T, Ikeda M, Inaba Y, Imanaka K, Okusaka T, Kanazawa S, Kaneko S, Kora S, Saito H, Furuse J, Matsui O, Yamashita T, Yokosuka O, Morita S, Arioka H, Kudo M, Arai Y.

Med Oncol. 2019 May 3;36(6):52. doi: 10.1007/s12032-019-1272-2.

PMID:
31053989
10.

Tenofovir alafenamide for hepatitis B virus infection including switching therapy from tenofovir disoproxil fumarate.

Kaneko S, Kurosaki M, Tamaki N, Itakura J, Hayashi T, Kirino S, Osawa L, Watakabe K, Okada M, Wang W, Shimizu T, Higuchi M, Takaura K, Yasui Y, Tsuchiya K, Nakanishi H, Takahashi Y, Watanabe M, Izumi N.

J Gastroenterol Hepatol. 2019 Apr 24. doi: 10.1111/jgh.14686. [Epub ahead of print]

PMID:
31017689
11.

Risk assessment of hepatocellular carcinoma development by magnetic resonance elastography in chronic hepatitis C patients who achieved sustained virological responses by direct-acting antivirals.

Tamaki N, Higuchi M, Kurosaki M, Kirino S, Osawa L, Watakabe K, Wang W, Okada M, Shimizu T, Takaura K, Takada H, Kaneko S, Yasui Y, Tsuchiya K, Nakanishi H, Itakura J, Takahashi Y, Enomoto N, Izumi N.

J Viral Hepat. 2019 Jul;26(7):893-899. doi: 10.1111/jvh.13103. Epub 2019 May 3.

PMID:
30974045
12.

Erratum: "Image-plate sensitivity to x rays at 2 to 60 keV" [Rev. Sci. Instrum. 90, 013506 (2019)].

Rosenberg MJ, Thorn DB, Izumi N, Williams D, Rowland M, Torres G, Haugh M, Hillyard P, Adelman N, Schuler T, Barrios MA, Holder JP, Schneider MB, Fournier KB, Bradley DK, Regan SP.

Rev Sci Instrum. 2019 Feb;90(2):029902. doi: 10.1063/1.5092602. No abstract available.

PMID:
30831772
13.

Intensity of SLX predicts distance of tumor spread through alveolar spaces in stage I lung adenocarcinoma.

Hara K, Mizuguchi S, Okada S, Izumi N, Tsukioka T, Komatsu H, Ohsawa M, Inaba M, Shibata T, Nishiyama N.

Thorac Cancer. 2019 Apr;10(4):832-838. doi: 10.1111/1759-7714.13008. Epub 2019 Feb 28.

14.

Cost-effectiveness analysis of lenvatinib treatment for patients with unresectable hepatocellular carcinoma (uHCC) compared with sorafenib in Japan.

Kobayashi M, Kudo M, Izumi N, Kaneko S, Azuma M, Copher R, Meier G, Pan J, Ishii M, Ikeda S.

J Gastroenterol. 2019 Jun;54(6):558-570. doi: 10.1007/s00535-019-01554-0. Epub 2019 Feb 20.

15.

Safety and efficacy of glecaprevir and pibrentasvir in Japanese hemodialysis patients with genotype 2 hepatitis C virus infection.

Suda G, Hasebe C, Abe M, Kurosaki M, Itakura J, Izumi N, Uchida Y, Mochida S, Haga H, Ueno Y, Abe K, Takahashi A, Ohira H, Tsukuda Y, Furuya K, Baba M, Yamamoto Y, Kobayashi T, Inoue J, Terasita K, Ohara M, Kawagishi N, Izumi T, Nakai M, Sho T, Natsuizaka M, Morikawa K, Ogawa K, Sakamoto N; NORTE Study Group.

J Gastroenterol. 2019 Jul;54(7):641-649. doi: 10.1007/s00535-019-01556-y. Epub 2019 Feb 18.

PMID:
30778716
16.

Real-life experience of lusutrombopag for cirrhotic patients with low platelet counts being prepared for invasive procedures.

Takada H, Kurosaki M, Nakanishi H, Takahashi Y, Itakura J, Tsuchiya K, Yasui Y, Tamaki N, Takaura K, Komiyama Y, Higuchi M, Kubota Y, Wang W, Okada M, Shimizu T, Watakabe K, Enomoto N, Izumi N.

PLoS One. 2019 Feb 15;14(2):e0211122. doi: 10.1371/journal.pone.0211122. eCollection 2019.

17.

Reply.

Tamaki N, Kurosaki M, Izumi N.

Clin Gastroenterol Hepatol. 2019 Jun;17(7):1419-1420. doi: 10.1016/j.cgh.2019.01.038. Epub 2019 Jan 30. No abstract available.

PMID:
30710699
18.

Image-plate sensitivity to x rays at 2 to 60 keV.

Rosenberg MJ, Thorn DB, Izumi N, Williams D, Rowland M, Torres G, Haugh M, Hillyard P, Adelman N, Schuler T, Barrios MA, Holder JP, Schneider MB, Fournier KB, Bradley DK, Regan SP.

Rev Sci Instrum. 2019 Jan;90(1):013506. doi: 10.1063/1.5053592. Erratum in: Rev Sci Instrum. 2019 Feb;90(2):029902.

PMID:
30709229
19.

Liver Resection for Multiple Hepatocellular Carcinomas: A Japanese Nationwide Survey.

Fukami Y, Kaneoka Y, Maeda A, Kumada T, Tanaka J, Akita T, Kubo S, Izumi N, Kadoya M, Sakamoto M, Nakashima O, Matsuyama Y, Kokudo T, Hasegawa K, Yamashita T, Kashiwabara K, Takayama T, Kokudo N, Kudo M; Liver Cancer Study Group of Japan.

Ann Surg. 2019 Jan 16. doi: 10.1097/SLA.0000000000003192. [Epub ahead of print]

PMID:
30672806
20.

Correction to: Positive correlation between sarcopenia and elevation of neutrophil/lymphocyte ratio in pathological stage IIIA (N2-positive) non-small cell lung cancer patients.

Tsukioka T, Izumi N, Mizuguchi S, Kyukwang C, Komatsu H, Toda M, Hara K, Miyamoto H, Nishiyama N.

Gen Thorac Cardiovasc Surg. 2019 Mar;67(3):348. doi: 10.1007/s11748-018-01056-5.

PMID:
30612288
21.

Prediction of Hepatocellular Carcinoma After Sustained Virological Responses Using Magnetic Resonance Elastography.

Higuchi M, Tamaki N, Kurosaki M, Watakabe K, Osawa L, Wang W, Okada M, Shimizu T, Takaura K, Takada H, Kaneko S, Yasui Y, Tsuchiya K, Nakanishi H, Itakura J, Takahashi Y, Izumi N.

Clin Gastroenterol Hepatol. 2018 Nov 28. pii: S1542-3565(18)31323-5. doi: 10.1016/j.cgh.2018.11.046. [Epub ahead of print]

PMID:
30502507
22.

Lusutrombopag Reduces Need for Platelet Transfusion in Patients With Thrombocytopenia Undergoing Invasive Procedures.

Hidaka H, Kurosaki M, Tanaka H, Kudo M, Abiru S, Igura T, Ishikawa T, Seike M, Katsube T, Ochiai T, Kimura K, Fukuhara T, Kano T, Nagata T, Tanaka K, Kurokawa M, Yamamoto K, Osaki Y, Izumi N, Imawari M.

Clin Gastroenterol Hepatol. 2019 May;17(6):1192-1200. doi: 10.1016/j.cgh.2018.11.047. Epub 2018 Nov 28.

23.

Non-invasive liver fibrosis assessment correlates with collagen and elastic fiber quantity in patients with hepatitis C virus infection.

Yasui Y, Abe T, Kurosaki M, Matsunaga K, Higuchi M, Tamaki N, Watakabe K, Okada M, Wang W, Shimizu T, Takaura K, Masugi Y, Nakanishi H, Tsuchiya K, Takahashi Y, Itakura J, Sakurai U, Hashiguchi A, Sakamoto M, Izumi N.

Hepatol Res. 2019 Jan;49(1):33-41. doi: 10.1111/hepr.13286. Epub 2018 Dec 26.

PMID:
30419152
24.

Prognosis associated with synchronous or metachronous multiple primary malignancies in patients with completely resected non-small cell lung cancer.

Komatsu H, Izumi N, Tsukioka T, Inoue H, Hara K, Miyamoto H, Nishiyama N.

Surg Today. 2019 Apr;49(4):343-349. doi: 10.1007/s00595-018-1738-4. Epub 2018 Nov 11.

PMID:
30417262
25.

On the system stability and calibration of the image plate/scanner system for plasma diagnosis at the National Ignition Facility.

Holder JP, Izumi N, Beach M, Ayers MJ, Bell P, Schneider M, Bradley DK, Kohut T, Ehrlich R, Cohen M, Ramirez R, Thorn D.

Rev Sci Instrum. 2018 Oct;89(10):10F123. doi: 10.1063/1.5039363.

PMID:
30399981
26.

X-ray streaked refraction enhanced radiography for inferring inflight density gradients in ICF capsule implosions.

Dewald EL, Landen OL, Masse L, Ho D, Ping Y, Thorn D, Izumi N, Berzak Hopkins L, Kroll J, Nikroo A, Koch JA.

Rev Sci Instrum. 2018 Oct;89(10):10G108. doi: 10.1063/1.5039346.

PMID:
30399872
27.

Simultaneous visualization of wall motion, beam propagation, and implosion symmetry on the National Ignition Facility (invited).

Izumi N, Meezan NB, Johnson S, Woodworth BN, Woods T, Jones OS, Landen OL, Kroll JJ, Vonhof S, Nikroo A, Jaquez J, Kangas K, Bailey C, Hardy M, Ehrlich R, Ralph J, Town RP, Bradley DK, Hinkel DE, Moore AS, Divol L, Young C, Moody JD.

Rev Sci Instrum. 2018 Oct;89(10):10K111. doi: 10.1063/1.5039364.

PMID:
30399855
28.

Implementing time resolved electron temperature capability at the NIF using a streak camera.

Khan SF, Jarrott LC, Patel PK, Izumi N, Ma T, MacPhee AG, Hatch B, Landen OL, Heinmiller J, Kilkenny JD, Bradley DK.

Rev Sci Instrum. 2018 Oct;89(10):10K117. doi: 10.1063/1.5039382.

PMID:
30399814
29.

Using multiple x-ray emission images of inertially confined implosions to identify spatial variations and estimate confinement volumes (invited).

Benedetti LR, Bradley DK, Khan SF, Izumi N, Ma T, Nagel SR, Pak A.

Rev Sci Instrum. 2018 Oct;89(10):10G105. doi: 10.1063/1.5039381.

PMID:
30399720
30.

High-Performance Indirect-Drive Cryogenic Implosions at High Adiabat on the National Ignition Facility.

Baker KL, Thomas CA, Casey DT, Khan S, Spears BK, Nora R, Woods T, Milovich JL, Berger RL, Strozzi D, Clark D, Hohenberger M, Hurricane OA, Callahan DA, Landen OL, Bachmann B, Benedetti R, Bionta R, Celliers PM, Fittinghoff D, Goyon C, Grim G, Hatarik R, Izumi N, Gatu Johnson M, Kyrala G, Ma T, Millot M, Nagel SR, Pak A, Patel PK, Turnbull D, Volegov PL, Yeamans C.

Phys Rev Lett. 2018 Sep 28;121(13):135001. doi: 10.1103/PhysRevLett.121.135001.

PMID:
30312055
31.

Thoracoscopic resection of mediastinal tumor in a patient with azygos continuation of the inferior vena cava.

Komatsu H, Izumi N, Tsukioka T, Inoue H, Hara K, Miyamoto H, Nishiyama N.

Gen Thorac Cardiovasc Surg. 2019 Aug;67(8):720-722. doi: 10.1007/s11748-018-1009-8. Epub 2018 Sep 18.

PMID:
30229437
32.

[Various clinical conditions after successful eradication of hepatitis C virus].

Kurosaki M, Izumi N.

Nihon Shokakibyo Gakkai Zasshi. 2018;115(9):768-776. doi: 10.11405/nisshoshi.115.768. Japanese. No abstract available.

PMID:
30197389
33.

Thermal Temperature Measurements of Inertial Fusion Implosions.

Jarrott LC, Bachmann B, Ma T, Benedetti LR, Field FE, Hartouni EP, Hatarik R, Izumi N, Khan SF, Landen OL, Nagel SR, Nora R, Pak A, Peterson JL, Schneider MB, Springer PT, Patel PK.

Phys Rev Lett. 2018 Aug 24;121(8):085001. doi: 10.1103/PhysRevLett.121.085001.

PMID:
30192614
34.

Real-world efficacy and safety of sofosbuvir + ribavirin for hepatitis C genotype 2: A nationwide multicenter study by the Japanese Red Cross Liver Study Group.

Akahane T, Kurosaki M, Itakura J, Tsuji K, Joko K, Kimura H, Nasu A, Ogawa C, Kojima Y, Hasebe C, Wada S, Uchida Y, Sohda T, Suzuki H, Yoshida H, Kusakabe A, Tamada T, Kobashi H, Mitsuda A, Kondo M, Shigeno M, Ide Y, Morita A, Kitamura T, Abe T, Izumi N.

Hepatol Res. 2019 Mar;49(3):264-270. doi: 10.1111/hepr.13246. Epub 2018 Oct 20.

PMID:
30171740
35.

Positive correlation between sarcopenia and elevation of neutrophil/lymphocyte ratio in pathological stage IIIA (N2-positive) non-small cell lung cancer patients.

Tsukioka T, Izumi N, Mizuguchi S, Kyukwang C, Komatsu H, Toda M, Hara K, Miyamoto H, Nishiyama N.

Gen Thorac Cardiovasc Surg. 2018 Dec;66(12):716-722. doi: 10.1007/s11748-018-0985-z. Epub 2018 Aug 13. Erratum in: Gen Thorac Cardiovasc Surg. 2019 Mar;67(3):348.

PMID:
30105630
36.

A randomized controlled trial of lusutrombopag in Japanese patients with chronic liver disease undergoing radiofrequency ablation.

Tateishi R, Seike M, Kudo M, Tamai H, Kawazoe S, Katsube T, Ochiai T, Fukuhara T, Kano T, Tanaka K, Kurokawa M, Yamamoto K, Osaki Y, Izumi N, Imawari M.

J Gastroenterol. 2019 Feb;54(2):171-181. doi: 10.1007/s00535-018-1499-2. Epub 2018 Aug 13.

37.

No Resistance to Tenofovir Alafenamide Detected through 96 Weeks of Treatment in Patients with Chronic Hepatitis B Infection.

Cathcart AL, Chan HL, Bhardwaj N, Liu Y, Marcellin P, Pan CQ, Shalimar, Buti M, Cox S, Parhy B, Zhou E, Martin R, Chang S, Lin L, Flaherty JF, Kitrinos KM, Gaggar A, Izumi N, Lim YS.

Antimicrob Agents Chemother. 2018 Sep 24;62(10). pii: e01064-18. doi: 10.1128/AAC.01064-18. Print 2018 Oct.

38.

Wisteria floribunda agglutinin-positive Mac-2 binding protein predicts early occurrence of hepatocellular carcinoma after sustained virologic response by direct-acting antivirals for hepatitis C virus.

Yasui Y, Kurosaki M, Komiyama Y, Takada H, Tamaki N, Watakabe K, Okada M, Wang W, Shimizu T, Kubota Y, Higuchi M, Takaura K, Tsuchiya K, Nakanishi H, Takahashi Y, Itakura J, Enomoto N, Izumi N.

Hepatol Res. 2018 Dec;48(13):1131-1139. doi: 10.1111/hepr.13233. Epub 2018 Aug 23.

PMID:
30030872
39.

Sofosbuvir-velpatasvir plus ribavirin in Japanese patients with genotype 1 or 2 hepatitis C who failed direct-acting antivirals.

Izumi N, Takehara T, Chayama K, Yatsuhashi H, Takaguchi K, Ide T, Kurosaki M, Ueno Y, Toyoda H, Kakizaki S, Tanaka Y, Kawakami Y, Enomoto H, Ikeda F, Jiang D, De-Oertel S, McNabb BL, Camus G, Stamm LM, Brainard DM, McHutchison JG, Mochida S, Mizokami M.

Hepatol Int. 2018 Jul;12(4):356-367. doi: 10.1007/s12072-018-9878-6. Epub 2018 Jul 20.

40.

Safety and efficacy of elbasvir and grazoprevir in Japanese hemodialysis patients with genotype 1b hepatitis C virus infection.

Suda G, Kurosaki M, Itakura J, Izumi N, Uchida Y, Mochida S, Hasebe C, Abe M, Haga H, Ueno Y, Masakane I, Abe K, Takahashi A, Ohira H, Furuya K, Baba M, Yamamoto Y, Kobayashi T, Kawakami A, Kumagai K, Terasita K, Ohara M, Kawagishi N, Umemura M, Nakai M, Sho T, Natsuizaka M, Morikawa K, Ogawa K, Sakamoto N; NORTE Study Group.

J Gastroenterol. 2019 Jan;54(1):78-86. doi: 10.1007/s00535-018-1495-6. Epub 2018 Jul 17.

PMID:
30019127
41.

Risk factors and health consequences of physical and emotional violence against children in Zimbabwe: a nationally representative survey.

Chigiji H, Fry D, Mwadiwa TE, Elizalde A, Izumi N, Baago-Rasmussen L, Maternowska MC.

BMJ Glob Health. 2018 Jun 26;3(3):e000533. doi: 10.1136/bmjgh-2017-000533. eCollection 2018.

42.

Fusion Energy Output Greater than the Kinetic Energy of an Imploding Shell at the National Ignition Facility.

Le Pape S, Berzak Hopkins LF, Divol L, Pak A, Dewald EL, Bhandarkar S, Bennedetti LR, Bunn T, Biener J, Crippen J, Casey D, Edgell D, Fittinghoff DN, Gatu-Johnson M, Goyon C, Haan S, Hatarik R, Havre M, Ho DD, Izumi N, Jaquez J, Khan SF, Kyrala GA, Ma T, Mackinnon AJ, MacPhee AG, MacGowan BJ, Meezan NB, Milovich J, Millot M, Michel P, Nagel SR, Nikroo A, Patel P, Ralph J, Ross JS, Rice NG, Strozzi D, Stadermann M, Volegov P, Yeamans C, Weber C, Wild C, Callahan D, Hurricane OA.

Phys Rev Lett. 2018 Jun 15;120(24):245003. doi: 10.1103/PhysRevLett.120.245003.

PMID:
29956968
43.

Neutrophil-lymphocyte ratio predicts recurrence in patients with resected stage 1 non-small cell lung cancer.

Mizuguchi S, Izumi N, Tsukioka T, Komatsu H, Nishiyama N.

J Cardiothorac Surg. 2018 Jun 27;13(1):78. doi: 10.1186/s13019-018-0763-0.

44.

Impact of pre-sarcopenia in sorafenib treatment for advanced hepatocellular carcinoma.

Takada H, Kurosaki M, Nakanishi H, Takahashi Y, Itakura J, Tsuchiya K, Yasui Y, Tamaki N, Takaura K, Komiyama Y, Higuchi M, Kubota Y, Wang W, Okada M, Enomoto N, Izumi N.

PLoS One. 2018 Jun 18;13(6):e0198812. doi: 10.1371/journal.pone.0198812. eCollection 2018.

45.

Genome-wide association study identified new susceptible genetic variants in HLA class I region for hepatitis B virus-related hepatocellular carcinoma.

Sawai H, Nishida N, Khor SS, Honda M, Sugiyama M, Baba N, Yamada K, Sawada N, Tsugane S, Koike K, Kondo Y, Yatsuhashi H, Nagaoka S, Taketomi A, Fukai M, Kurosaki M, Izumi N, Kang JH, Murata K, Hino K, Nishina S, Matsumoto A, Tanaka E, Sakamoto N, Ogawa K, Yamamoto K, Tamori A, Yokosuka O, Kanda T, Sakaida I, Itoh Y, Eguchi Y, Oeda S, Mochida S, Yuen MF, Seto WK, Poovorawan Y, Posuwan N, Mizokami M, Tokunaga K.

Sci Rep. 2018 May 21;8(1):7958. doi: 10.1038/s41598-018-26217-7.

46.

Avatrombopag Before Procedures Reduces Need for Platelet Transfusion in Patients With Chronic Liver Disease and Thrombocytopenia.

Terrault N, Chen YC, Izumi N, Kayali Z, Mitrut P, Tak WY, Allen LF, Hassanein T.

Gastroenterology. 2018 Sep;155(3):705-718. doi: 10.1053/j.gastro.2018.05.025. Epub 2018 May 17.

47.

96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection.

Agarwal K, Brunetto M, Seto WK, Lim YS, Fung S, Marcellin P, Ahn SH, Izumi N, Chuang WL, Bae H, Sharma M, Janssen HLA, Pan CQ, Çelen MK, Furusyo N, Shalimar D, Yoon KT, Trinh H, Flaherty JF, Gaggar A, Lau AH, Cathcart AL, Lin L, Bhardwaj N, Suri V, Mani Subramanian G, Gane EJ, Buti M, Chan HLY; GS-US-320-0110; GS-US-320-0108 Investigators.

J Hepatol. 2018 Apr;68(4):672-681. doi: 10.1016/j.jhep.2017.11.039. Epub 2018 Jan 17.

PMID:
29756595
48.

Pulmonary Resection for Lung Cancer Following Transcatheter Aortic Valve Implantation for Severe Aortic Valve Stenosis: A Case Report.

Komatsu H, Izumi N, Tsukioka T, Chung K, Toda M, Hara K, Nishiyama N.

Ann Thorac Cardiovasc Surg. 2018 Apr 26. doi: 10.5761/atcs.cr.18-00028. [Epub ahead of print]

49.

Novel quantitative assessment system of liver steatosis using a newly developed attenuation measurement method.

Tamaki N, Koizumi Y, Hirooka M, Yada N, Takada H, Nakashima O, Kudo M, Hiasa Y, Izumi N.

Hepatol Res. 2018 Sep;48(10):821-828. doi: 10.1111/hepr.13179. Epub 2018 May 18.

PMID:
29679473
50.

Does interferon-free direct-acting antiviral therapy for hepatitis C after curative treatment for hepatocellular carcinoma lead to unexpected recurrences of HCC? A multicenter study by the Japanese Red Cross Hospital Liver Study Group.

Mashiba T, Joko K, Kurosaki M, Ochi H, Osaki Y, Kojima Y, Nakata R, Goto T, Takehiro A, Kimura H, Mitsuda A, Kawanami C, Uchida Y, Ogawa C, Kusakabe A, Narita R, Ide Y, Abe T, Tsuji K, Kitamura T, Okada K, Sohda T, Shigeno M, Satou T, Izumi N.

PLoS One. 2018 Apr 16;13(4):e0194704. doi: 10.1371/journal.pone.0194704. eCollection 2018.

Supplemental Content

Support Center